Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anne Kaltoft is active.

Publication


Featured researches published by Anne Kaltoft.


Journal of the American College of Cardiology | 2016

EARLY HEALING AFTER TREATMENT OF CORONARY LESIONS BY EVEROLIMUS OR BIOLIMUS ELUTING BIORESORBABLE POLYMER STENTS: THE SORT-OUT VIII OPTICAL COHERENCE TOMOGRAPHY STUDY

Ida Riise Balleby; Lene Nyhus Andreasen; Lasse Hebsgaard; Trine Ørhøj Barkholt; Christian Terkelsen; Lisette Okkels Jensen; Emil Holck; Michael Maeng; Lars Krusell; Jouke Dijkstra; Lisbeth Antonsen; Anne Kaltoft; Troels Munck Nielsen; Jakob Hjort; Steen Kristensen; Mikkel Hougaard; Shengxian Tu; Hans Erik Bøtker; Jens Lassen; Evald Christiansen; Niels V. Holm

Improved early healing after drug eluting stent (DES) implantation may reduce the risk of early stent thrombosis. We aimed to compare early healing patterns after implantation of a 74 µm thick, everolimus-eluting biodegradable polymer stent (Synergy, Boston Scientific, USA) or a 120 µm thick,


Journal of the American College of Cardiology | 2013

RISK FOR PERSISTENT RENAL DYSFUNCTION IN PATIENTS WITH CONTRAST–INDUCED NEPHROPATHY AFTER PRIMARY PCI

Per Thayssen; Henrik Steen Hansen; Anne Kaltoft; Jan Ravkilde; Knud Noerregaard Hansen; Hans Erik Bøtker; Hans-Henrik Tilsted; Anders Junker; L Thuesen; Karsten Tange Veien; Lisette Okkels Jensen

Contrast–induced nephropathy (CIN) is a serious condition in patients with ST segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI). The risk of persistent renal dysfunction after CIN is limited studied. We investigated the risk of acute CIN


Journal of the American College of Cardiology | 2012

IMPACT OF LESION LENGTH ON OUTCOMES AFTER REVASCULARIZATION WITH EVEROLIMUS AND SIROLIMUS ELUTING STENTS. A SUBSTUDY OF THE SORT OUT IV TRIAL

Mikkel Hougaard; Lisette Okkels Jensen; Per Thayssen; Anne Kaltoft; Hans-Henrik Tilsted; Michael Maeng; Evald Christiansen; Jan Ravkilde; Morten Madsen; Anders Junker; L Thuesen; Jens Lassen

Randomized trials comparing outcomes after implantation of first generation drug-eluting stents (DES) versus second generation DES in long lesions are limited. Stenting of long lesions might be associated with higher rates of adverse events. In this substudy of the SORT OUT IV trial, we assessed the


Journal of the American College of Cardiology | 2012

OUTCOMES AFTER REVASCULARIZATION WITH EVEROLIMUS AND SIROLIMUS ELUTING STENTS IN PATIENTS WITH SMALL AND LARGE CORONARY ARTERIES. A SUBSTUDY OF THE SORT OUT IV TRIAL

Lisbeth Antonsen; Lisette Okkels Jensen; Per Thayssen; Evald Christiansen; Michael Maeng; Hans-Henrik Tilsted; Jan Ravkilde; Anne Kaltoft; Henrik Steen Hansen; Morten Madsen; L Thuesen; Jens Lassen


American College of Cardiology. Journal | 2011

Impact of Diabetes on Clinical Outcomes after Revascularization with Everolimus- and Sirolimus-Eluting Stents

Anders Junker; Lisette Okkels Jensen; Per Thayssen; Michael Maeng; Hans-Henrik Tilsted; Anne Kaltoft; Knud Nørregaard Hansen; Steen Dalby Kristensen; Jan Ravkilde; Mette Madsen; Henrik Toft Sørensen; L Thuesen; Jørgen Fr Lassen


Journal of the American College of Cardiology | 2015

IMPACT OF DIABETES ON LONG-TERM CLINICAL OUTCOMES AFTER REVASCULARIZATION WITH EVEROLIMUS- AND SIROLIMUS-ELUTING STENTS: FROM THE SORT OUT IV TRIAL

Lisette Okkels Jensen; Michael Maeng; Per Thayssen; Jan Ravkilde; Lars Krusell; Knud Noerregaard Hansen; Anne Kaltoft; Henrik Steen Hansen; Anders Junker; Anton Villadsen; Klara Berencsi; Evald Christiansen; Jens Lassen


Journal of the American College of Cardiology | 2015

FIVE-YEAR STENT-RELATED AND PATIENT-RELATED OUTCOMES IN PATIENTS WITH AND WITHOUT DIABETES: FROM THE SORT OUT IV TRIAL

Lisette Okkels Jensen; Michael Maeng; Per Thayssen; Jan Ravkilde; Lars Krusell; Knud Noerregaard Hansen; Anne Kaltoft; Henrik Steen Hansen; Anders Junker; Anton Villadsen; Klara Berencsi; Evald Christiansen; Jens Lassen


Journal of the American College of Cardiology | 2014

LONG-TERM CLINICAL OUTCOMES OF EVEROLIMUS-ELUTING STENTS VERSUS SIROLIMUS-ELUTING STENTS IN PATIENTS WITH CORONARY ARTERY DISEASE: SORT OUT IV 4-YEAR

Lisette Okkels Jensen; Per Thayssen; Evald Christiansen; Michael Maeng; Jan Ravkilde; Knud Noerregaard Hansen; Henrik Steen Hansen; Lars Krusell; Klara Berencsi; Anne Kaltoft; Hans-Henrik Tilsted; Anders Junker; Jens Lassen


Journal of the American College of Cardiology | 2013

VERY LATE STENT THROMBOSIS AFTER REVASCULARIZATION WITH EVEROLIMUS- AND SIROLIMUS-ELUTING STENTS FROM THE SORT OUT IV TRIAL

Lisette Okkels Jensen; Per Thayssen; Evald Christiansen; Michael Maeng; Jan Ravkilde; Knud Noerregaard Hansen; Henrik Steen Hansen; Lars Krusell; Klara Berencsi; Anne Kaltoft; Hans-Henrik Tilsted; Anders Junker; Jens Lassen


Journal of the American College of Cardiology | 2012

DEFINITE AND PROBABLE STENT THROMBOSIS AFTER REVASCULARIZATION WITH EVEROLIMUS- AND SIROLIMUS-ELUTING STENTS. FROM THE SORT OUT IV TRIAL

Lisette Okkels Jensen; Per Thayssen; Michael Maeng; Hans-Henrik Tilsted; Anne Kaltoft; Knud Noerregaard Hansen; Evald Christiansen; Anders Junker; Jan Ravkilde; L Thuesen; Jens Lassen

Collaboration


Dive into the Anne Kaltoft's collaboration.

Top Co-Authors

Avatar

Michael Maeng

Odense University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Per Thayssen

University of Southern Denmark

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

L Thuesen

Odense University Hospital

View shared research outputs
Top Co-Authors

Avatar

Anders Junker

Odense University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jens Lassen

Odense University Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge